Protein oxidative modifications in neurodegenerative diseases: from advances in detection and modelling to their use as disease biomarkers
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
doi: 10.1210/en.2005-0323 101 SmithJT
In addition to GSH effects with T cells, a decrease in GSH plays similar roles in MS as it does in AD and PD, namely, to mark an increase in oxidative stress and inflammation in the respective disease (Choi et al., 2018)
Whether you have oily, dry, or combination skin, this lightweight lotion absorbs effortlessly, delivering intense hydration without leaving a greasy residue